Indolylmaleimide derivatives as PKC inhibitors
US7648989B2 · kind B2 · utility
9Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 2005 |
| Grant date | Jan 19, 2010 |
| Priority date | — |
| Expiry date | Jan 10, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to PKC inhibitors which are able to selectively inhibit e.g. the and optionally 0, isoforms of PKC, and their use in particular in transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.